Your browser doesn't support javascript.
loading
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19.
Delaveris, Corleone S; Wilk, Aaron J; Riley, Nicholas M; Stark, Jessica C; Yang, Samuel S; Rogers, Angela J; Ranganath, Thanmayi; Nadeau, Kari C; Blish, Catherine A; Bertozzi, Carolyn R.
Afiliación
  • Delaveris CS; Department of Chemistry, Stanford University, Stanford, California 94305, United States.
  • Wilk AJ; ChEM-H, Stanford University, Stanford, California 94305, United States.
  • Riley NM; Stanford Medical Scientist Training Program, Stanford University, Stanford, California 94305, United States.
  • Stark JC; Stanford Immunology Program, Stanford University, Stanford, California 94305, United States.
  • Yang SS; Department of Medicine, Stanford University, Stanford, California 94305, United States.
  • Rogers AJ; Department of Chemistry, Stanford University, Stanford, California 94305, United States.
  • Ranganath T; Department of Chemistry, Stanford University, Stanford, California 94305, United States.
  • Nadeau KC; Department of Emergency Medicine, Stanford University, Stanford, California 94305, United States.
  • Blish CA; Department of Medicine, Stanford University, Stanford, California 94305, United States.
  • Bertozzi CR; Department of Medicine, Stanford University, Stanford, California 94305, United States.
ACS Cent Sci ; 7(4): 650-657, 2021 Apr 28.
Article en En | MEDLINE | ID: mdl-34056095

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article